Literature DB >> 18296649

Binding of the retinoblastoma protein is not the determinant for stable repression of some E2F-regulated promoters in muscle cells.

Marie Vandromme1, Catherine Chailleux, Fabrice Escaffit, Didier Trouche.   

Abstract

Permanent silencing of E2F-dependent genes is a hallmark of the irreversible cell cycle exit that characterizes terminally differentiated and senescent cells. The determinant of this silencing during senescence has been proposed to be the binding of the retinoblastoma protein Rb and the consequent methylation of H3K9. During ex vivo skeletal muscle differentiation, while most cells terminally differentiate and form myotubes, a subset of myoblasts remains quiescent and can be reinduced by growth factor stimulation to enter the cell cycle. Thus, differentiating cells are composed of two different populations: one in which E2F-dependent genes are permanently repressed and the other not. We observed that, in a manner reminiscent to senescent cells, permanent silencing of the E2F-dependent cdc6, dhfr, and p107 promoters in myotubes was associated with a specific increase in H3K9 trimethylation. To investigate the role of Rb in this process, we developed a reliable method to detect Rb recruitment by chromatin immunoprecipitation. Surprisingly, we observed that Rb was recruited to these promoters more efficiently in quiescent cells than in myotubes. Thus, our data indicate that during muscle differentiation, permanent silencing and H3K9 trimethylation of some E2F-dependent genes are not directly specified by Rb binding, in contrast to what is proposed for senescence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18296649     DOI: 10.1158/1541-7786.MCR-07-0381

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  6 in total

1.  Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.

Authors:  Deborah L Burkhart; Stacey E Wirt; Anne-Flore Zmoos; Michael S Kareta; Julien Sage
Journal:  PLoS Genet       Date:  2010-06-24       Impact factor: 5.917

2.  Maged1, a new regulator of skeletal myogenic differentiation and muscle regeneration.

Authors:  Tuan H N Nguyen; Mathieu J M Bertrand; Christiane Sterpin; Younes Achouri; Olivier R Y De Backer
Journal:  BMC Cell Biol       Date:  2010-07-20       Impact factor: 4.241

3.  Retinoblastoma/p107/p130 pocket proteins: protein dynamics and interactions with target gene promoters.

Authors:  Kristy R Stengel; Chellappagounder Thangavel; David A Solomon; Steve P Angus; Yi Zheng; Erik S Knudsen
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

4.  Regulation of RB transcription in vivo by RB family members.

Authors:  Deborah L Burkhart; Lynn K Ngai; Caitlin M Roake; Patrick Viatour; Chellappagounder Thangavel; Victoria M Ho; Erik S Knudsen; Julien Sage
Journal:  Mol Cell Biol       Date:  2010-01-25       Impact factor: 4.272

5.  A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation.

Authors:  Laure Verrier; Fabrice Escaffit; Catherine Chailleux; Didier Trouche; Marie Vandromme
Journal:  PLoS Genet       Date:  2011-06-02       Impact factor: 5.917

6.  G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation.

Authors:  Vinay Kumar Rao; Jin Rong Ow; Shilpa Rani Shankar; Narendra Bharathy; Jayapal Manikandan; Yaju Wang; Reshma Taneja
Journal:  Nucleic Acids Res       Date:  2016-05-26       Impact factor: 16.971

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.